---
title: O.C.G.A. § 31-52-23. Request to manufacturer.
collection: code
id: 31-52-23
cite_as: O.C.G.A. § 31-52-23 (2025)
canonical_url: https://georgiacommons.org/code/31-52-23
md_url: https://georgiacommons.org/code/31-52-23.md
text_url: https://georgiacommons.org/code/31-52-23/text
source_url: https://www.legis.ga.gov/api/document/docs/default-source/joint-features-document-library/t31-(v23)-2025-pdf.pdf?sfvrsn=da7ded69_0#page=1094
date: 2025
status: active
corpus_version: 2025-supplement-89aa39ab3c68
license: CC0-1.0
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/code/31-52.md
previous: https://georgiacommons.org/code/31-52-22.md
next: https://georgiacommons.org/code/31-52-24.md
index: https://georgiacommons.org/code/index.md
version: the only printed version
in_force: true
current_through: Including Acts of the 2025 Session of the General Assembly of Georgia
heading_path: HEALTH / TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES / INDIVIDUALIZED INVESTIGATIONAL TREATMENT
---

# O.C.G.A. § 31-52-23. Request to manufacturer.

(a) A manufacturer or an eligible entity may make available an individualized investigational treatment to an eligible patient, and an eligible patient may request such treatment from such manufacturer or facility pursuant to this article; provided, however, that nothing in this article shall be construed to require that such manufacturer or facility make available such treatment to such patient.

(b) A manufacturer or an eligible facility may provide an individualized investigational treatment to an eligible patient:

(1) Without receiving compensation; or

(2) With the requirement that the eligible patient pays the costs of or the costs associated with the manufacture of the individualized investigational treatment.

## History

Code 1981, § 31-52-23, enacted by Ga. L. 2025, p. 455, § 5/SB 72, effective July 1, 2025.